Board Meeting Details
The Board of Directors meeting was held on 30th October 2026 from 4:00 PM to 5:45 PM where the financial results were approved.
Financial Results - Quarterly Performance (Q2 FY2026-27)
- Revenue From Operations: ₹123.11 lakhs
- Other Income: ₹63.83 lakhs
- Total Income: ₹186.94 lakhs
- Total Expenses: ₹167.38 lakhs
- Profit before tax: ₹19.55 lakhs
- Tax expense (Deferred tax): ₹(2.40) lakhs
- Profit for the quarter: ₹21.95 lakhs
- Other Comprehensive Income: ₹(0.86) lakhs
- Total Comprehensive Income: ₹21.09 lakhs
- Basic EPS: ₹8.61
- Diluted EPS: ₹8.61
Financial Results - Half Year Performance (H1 FY2026-27)
- Revenue From Operations: ₹188.51 lakhs
- Other Income: ₹63.83 lakhs
- Total Income: ₹252.34 lakhs
- Total Expenses: ₹269.77 lakhs
- Loss before tax: ₹(17.43) lakhs
- Tax expense (Deferred tax): ₹(7.32) lakhs
- Loss for the period: ₹(10.12) lakhs
- Other Comprehensive Income: ₹(12.90) lakhs
- Total Comprehensive Loss: ₹(23.01) lakhs
- Basic EPS: ₹(9.39)
- Diluted EPS: ₹(9.39)
Comparative Performance
Quarterly Comparison (Q2 FY2026-27 vs Q2 FY2025-26):
- Revenue from operations increased from ₹0.00 lakhs to ₹123.11 lakhs
- Profit improved from loss of ₹(25.95) lakhs to profit of ₹21.95 lakhs
Sequential Comparison (Q2 FY2026-27 vs Q1 FY2026-27):
- Revenue increased from ₹65.40 lakhs to ₹123.11 lakhs
- Performance improved from loss of ₹(32.06) lakhs to profit of ₹21.95 lakhs
Balance Sheet Position (as at 30th September 2026)
- Total Assets: ₹487.21 lakhs (Previous: ₹103.84 lakhs as at 31st March 2026)
- Non-current assets: ₹21.47 lakhs
- Current assets: ₹465.74 lakhs (including Trade receivables: ₹147.73 lakhs, Cash: ₹29.39 lakhs, Other current assets: ₹284.22 lakhs)
- Total Equity: Negative ₹(362.61) lakhs (Equity share capital: ₹24.50 lakhs, Other equity: Negative ₹(387.11) lakhs)
- Non-current liabilities: ₹174.04 lakhs (including Other non-current liabilities: ₹150.00 lakhs)
- Current liabilities: ₹675.78 lakhs (including Borrowings: ₹463.22 lakhs, Trade payables: ₹109.41 lakhs, Other current liabilities: ₹98.51 lakhs)
Cash Flow Statement (Half Year ended 30th September 2026)
- Net cash used in operating activities: ₹(113.83) lakhs
- Net cash flow from investing activities: ₹0.00 lakhs
- Net cash generated from financing activities: ₹141.87 lakhs (mainly from borrowings: ₹149.53 lakhs)
- Net increase in cash: ₹28.04 lakhs
- Cash at beginning: ₹1.35 lakhs
- Cash at end: ₹29.39 lakhs
Key Expense Breakdown (Half Year)
- Employee benefits expense: ₹178.72 lakhs
- Purchases of Stock-in-Trade: ₹55.38 lakhs
- Finance costs: ₹7.13 lakhs
- Depreciation and amortization: ₹31.92 lakhs
- Other expenses: ₹1.03 lakhs
Additional Information
- Paid-up equity share capital: 2.45 lakh shares of face value ₹10/- each
- No investor complaints remained pending as of 30th September 2026
- Financial results are available on company website: https://wardwizardhealthcare.com
- The results will be published in newspapers as required by Listing Regulations